Nitric Oxide Synthase activity in major depressive episodes before and after antidepressant treatment: Results of a large case-control treatment study

Psychological Medicine
E LoebEmmanuelle Corruble

Abstract

Nitric oxide synthase (NOS) activity, an enzyme potentially involved in the major depressive episodes (MDE), could be indirectly measured by the L-Citrulline/L-Arginine ratio (L-Cit/L-Arg). The aim of this study was: (1) to compare the NOS activity of patients with a MDE to that of healthy controls (HC); (2) to assess its change after antidepressant treatment. A total of 460 patients with a current MDE in a context of major depressive disorder (MDD) were compared to 895 HC for NOS activity (L-Cit/L-Arg plasma ratio). L-Arg and L-Cit plasma levels were measured using a MS-based liquid chromatography method. Depressed patients were assessed at baseline, and after 3 and 6 months of antidepressant treatment for depression severity and clinical response. Depressed patients had a lower NOS activity than HC at baseline [0.31 ± 0.09 v. 0.38 ± 0.12; 95% confidence interval (CI) -0.084 to -0.062, p < 0.0001]. Lower NOS activity at baseline predicted a higher response rate [odds ratio (OR) = 29.20; 95% CI 1.58-536.37; p = 0.023]. NOS activity in depressed patients increased significantly up to 0.34 ± 0.08 after antidepressant treatment (Est = 0.0034; 95% CI 0.0002-0.0067; p = 0.03). Depressed patients have a decreased NOS activity that im...Continue Reading

References

Dec 31, 1991·Biochemical and Biophysical Research Communications·H H Schmidt, F Murad
Jun 15, 1989·Biochemical and Biophysical Research Communications·D J StuehrC F Nathan
Mar 1, 1994·The Biochemical Journal·R G Knowles, S Moncada
Apr 17, 1995·Biochemical and Biophysical Research Communications·P RhodesP ] Rhodes PM [corrected to Rhodes
Feb 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S Archer
Apr 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·D J HigmanJ T Powell
Jul 1, 1996·American Journal of Respiratory and Critical Care Medicine·D H YatesP J Barnes
Jul 1, 1997·Molecular Psychiatry·H Y YunT M Dawson
May 13, 1999·Biochimica Et Biophysica Acta·M Kelm
Feb 11, 2000·Japanese Journal of Pharmacology·T IshibashiM Nishio
Feb 13, 2001·Journal of Applied Physiology·M H LaughlinE M Price
Mar 14, 2001·Journal of Affective Disorders·E SuzukiM Asai
Mar 29, 2001·Progress in Neurobiology·H Wiesinger
Apr 11, 2001·Circulation·H Suzuki, M Colasanti
Dec 4, 2001·Brain Research. Molecular Brain Research·M Fernández-CancioJ J Centelles
Dec 18, 2002·Annals of the New York Academy of Sciences·H-G BernsteinB Baumann
Jun 28, 2003·International Journal of Methods in Psychiatric Research·Philip S WangRonald C Kessler
Aug 6, 2003·American Journal of Physiology. Cell Physiology·Yong Chool Boo, Hanjoong Jo
Aug 16, 2003·Journal of Clinical Psychopharmacology·Nathalie LaraJean-Michel Le Mellédo
Sep 23, 2003·European Journal of Gastroenterology & Hepatology·Iain A MurrayRichard G Long
Oct 30, 2003·Free Radical Biology & Medicine·Petra KleinbongardMalte Kelm
Nov 19, 2003·Journal of Clinical Psychopharmacology·Nathalie LaraJean-Michel Le Mellédo
Jul 16, 2004·Heart·P JepsenH T Sørensen
Dec 1, 2004·Journal of Neurochemistry·B KarolewiczG A Ordway
Dec 1, 2004·The American Journal of Psychiatry·R Michael BagbyMargarita B Marshall
Aug 5, 2005·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Stephan GielenRainer Hambrecht
Dec 2, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Wendy ChrapkoJean-Michel Le Mellédo
May 27, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yong-Ku KimBun-Hee Lee
Jun 20, 2006·Veterinary Clinical Pathology·Martina Klinkon, Manica Cerne
Aug 31, 2006·Neurochemical Research·Rama SethuramanShinro Tachibana
Sep 21, 2007·Nature Reviews. Neuroscience·Vittorio CalabreseAnna Maria Giuffrida Stella
Oct 5, 2007·Pharmacology, Biochemistry, and Behavior·A SpiacciR M W Oliveira
Aug 12, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Atsuko Ikenouchi-SugitaJun Nakamura
Feb 1, 2011·Psychiatry Research·Goran TrajkovićJelena Marinković
Feb 22, 2011·Nitric Oxide : Biology and Chemistry·Ashish Dhir, S K Kulkarni
May 4, 2011·Psychosomatic Medicine·Ronald G GarcíaPatricio López-Jaramillo
Aug 9, 2012·Archives of Medical Research·Adriana Mayoral-MarilesRosalinda Guevara-Guzmán

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.